Plasma Antioxidants Are Associated with Impaired Lung Function and COPD Exacerbations in Smokers

Autor Nicks, Michael E., O’Brien, Maureen M., Bowler, Russell P.
Vydáno v COPD (2011)

Second Malignant Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low-Dose Radiation and Chemotherapy

Autor O'Brien, Maureen M., Donaldson, Sarah S., Balise, Raymond R., Whittemore, Alice S., Link, Michael P.
Vydáno v J Clin Oncol (2010)

Expression and silencing of microtubule-associated protein Tau in breast cancer cells

Autor Spicakova, Tatiana, O’Brien, Maureen M., Duran, George E., Sweet-Cordero, Alejandro, Sikic, Branimir I.
Vydáno 2010

Cost-Effectiveness Analysis of an Adherence-Promotion Intervention for Children With Leukemia: A Markov Model-Based Simulation

Autor McGrady, Meghan E, Eckman, Mark H, O’Brien, Maureen M, Pai, Ahna L H
Vydáno v J Pediatr Psychol (2018)

Castleman disease in pediatrics: insights on presentation, treatment and outcomes from a two-site retrospective cohort study

Autor Sopfe, Jenna, Endres, Ashley, Campbell, Kristen, Hayes, Kari, Trout, Andrew T., Liang, Xiayuan, Lorsbach, Robert, O’Brien, Maureen M., Cost, Carrye R.
Vydáno v Pediatr Blood Cancer (2019)

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Autor Gore, Lia, Locatelli, Franco, Zugmaier, Gerhard, Handgretinger, Rupert, O’Brien, Maureen M., Bader, Peter, Bhojwani, Deepa, Schlegel, Paul-Gerhardt, Tuglus, Catherine A., von Stackelberg, Arend
Vydáno v Blood Cancer J (2018)

Cardiomyopathy in Children With Down Syndrome Treated for Acute Myeloid Leukemia: A Report From the Children's Oncology Group Study POG 9421

Autor O'Brien, Maureen M., Taub, Jeffrey W., Chang, Myron N., Massey, Gita V., Stine, Kimo C., Raimondi, Susana C., Becton, David, Ravindranath, Yaddanapudi, Dahl, Gary V.
Vydáno 2008

Bortezomib Reinduction Chemotherapy in High-Risk ALL in First Relapse: A Report from the Children’s Oncology Group

Autor Horton, Terzah M., Whitlock, James A., Lu, Xiaomin, O’Brien, Maureen M., Borowitz, Michael J., Devidas, Meenakshi, Raetz, Elizabeth A., Brown, Patrick A., Carroll, William L., Hunger, Stephen P.
Vydáno v Br J Haematol (2019)

Phase I Study of Valspodar (PSC-833) with Mitoxantrone and Etoposide in Refractory and Relapsed Pediatric Acute Leukemia: A Report from the Children’s Oncology Group

Autor O’Brien, Maureen M., Lacayo, Norman J., Lum, Bert L., Kshirsagar, Smita, Buck, Steven, Ravindranath, Yaddanapudi, Bernstein, Mark, Weinstein, Howard, Chang, Myron N., Arceci, Robert J., Sikic, Branimir I., Dahl, Gary V.
Vydáno 2010

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance

Autor Ramsey, Laura B., Balis, Frank M., O'Brien, Maureen M., Schmiegelow, Kjeld, Pauley, Jennifer L., Bleyer, Archie, Widemann, Brigitte C., Askenazi, David, Bergeron, Sharon, Shirali, Anushree, Schwartz, Stefan, Vinks, Alexander A., Heldrup, Jesper
Vydáno v Oncologist (2017)

Prognostic Features in Acute Megakaryoblastic Leukemia in Children without Down Syndrome: A Report from the AML02 Multicenter Trial and the Children’s Oncology Group study POG 9421...

Autor O'Brien, Maureen M., Cao, Xueyuan, Pounds, Stanley, Dahl, Gary V., Raimondi, Susana C., Lacayo, Norman J., Taub, Jeffrey, Chang, Myron, Weinstein, Howard J., Ravindranath, Yaddanapudi, Inaba, Hiroto, Campana, Dario, Pui, Ching-Hon, Rubnitz, Jeffrey E.
Vydáno v Leukemia (2012)

Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy

Autor Sterling, Maya, Al-Ismaili, Zubaida, McMahon, Kelly R., Piccioni, Melissa, Pizzi, Michael, Mottes, Theresa, Lands, Larry C., Abish, Sharon, Fleming, Adam J., Bennett, Michael R., Palijan, Ana, Devarajan, Prasad, Goldstein, Stuart L., O’Brien, Maureen M., Zappitelli, Michael
Vydáno v Pediatr Blood Cancer (2017)

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Autor Bhojwani, Deepa, Sposto, Richard, Shah, Nirali N., Rodriguez, Vilmarie, Yuan, Constance, Stetler-Stevenson, Maryalice, O’Brien, Maureen M., McNeer, Jennifer L., Quereshi, Amrana, Cabannes, Aurelie, Schlegel, Paul, Rossig, Claudia, Dalla-Pozza, Luciano, August, Keith, Alexander, Sarah, Bourquin, Jean-Pierre, Zwaan, Michel, Raetz, Elizabeth A., Loh, Mignon L., Rheingold, Susan R.
Vydáno v Leukemia (2018)

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Autor Bhojwani, Deepa, Sposto, Richard, Shah, Nirali N., Rodriguez, Vilmarie, Yuan, Constance, Stetler-Stevenson, Maryalice, O’Brien, Maureen M., McNeer, Jennifer L., Quereshi, Amrana, Cabannes, Aurelie, Schlegel, Paul, Rossig, Claudia, Dalla-Pozza, Luciano, August, Keith, Alexander, Sarah, Bourquin, Jean-Pierre, Zwaan, Michel, Raetz, Elizabeth A., Loh, Mignon L., Rheingold, Susan R.
Vydáno v Leukemia (2019)

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study

Autor Blink, Marjolein, Zimmermann, Martin, von Neuhoff, Christine, Reinhardt, Dirk, de Haas, Valerie, Hasle, Henrik, O’Brien, Maureen M., Stark, Batia, Tandonnet, Julie, Pession, Andrea, Tousovska, Katerina, Cheuk, Daniel K.L., Kudo, Kazuko, Taga, Takashi, Rubnitz, Jeffrey E., Haltrich, Iren, Balwierz, Walentyna, Pieters, Rob, Forestier, Erik, Johansson, Bertil, van den Heuvel-Eibrink, Marry M., Zwaan, C. Michel
Vydáno 2014